Summary & Overview
HCPCS S5561: Insulin Delivery Device, Reusable Pen 3 ml
HCPCS Level II code S5561 designates a reusable insulin delivery pen in the 3 ml size, a durable medical device widely used in diabetes management. Nationally, reusable insulin pens influence outpatient device procurement, patient self-management of insulin therapy, and durable medical equipment billing patterns across public and private payers. This code matters for device coverage determinations, preauthorization workflows, and supply provisioning in ambulatory and home settings.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what S5561 represents clinically and operationally, how major payers typically handle reimbursement and coverage parameters at a high level, and where this code fits in billing workflows for durable medical equipment and diabetes supplies. The publication provides benchmarks for utilization and reimbursement where available, summarizes common policy levers affecting access (such as coverage criteria and documentation requirements), and outlines clinical context for device selection and typical sites of service. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code S5561 describes an insulin delivery device, reusable pen; 3 ml size. This item is a durable medical device intended for subcutaneous insulin administration using replaceable cartridges or insulin cartridges compatible with reusable pen mechanisms. The service type is durable medical equipment / insulin delivery device. The typical site of service for provision and use includes outpatient clinics, durable medical equipment suppliers, home settings, and other ambulatory care environments where patients obtain and use insulin delivery devices.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with insulin-dependent diabetes mellitus prescribed a reusable insulin pen device in a 3 mL cartridge size for subcutaneous insulin delivery. The patient presents to an outpatient endocrinology clinic or a primary care office for training and device issuance, or obtains the device via durable medical equipment distribution at a pharmacy or home health supply company. The clinical workflow includes verification of prescription and insurance coverage, selection of the appropriate reusable pen and compatible insulin cartridges, device demonstration by a clinician or diabetes educator, patient return demonstration of correct loading, dose dialing and injection technique, counseling on storage and needle/syringe compatibility, and documentation of device serial/lot number in the medical record. Typical sites of service are outpatient clinic, physician office, retail pharmacy, or home delivery by a durable medical equipment supplier.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifiers | Routine billing without modifier usage |
52 | Reduced services | When a portion of the device supply or accompanying service is reduced |